Thanks to this imitation hormone, you get increased insulin, which helps control your blood sugar levels
the approved options remain semaglutide and tirzepatide
Even though there are studies showing an effective and safe reduction of glycaemic parameters with initial combination therapies with DPP-4 inhibitors, initial combinations are not generally recommended in the new treatment recommendations (7072, 7685)
The most commonly reported side effects are mild and tend to resolve within the first week of use
Recently, BCGs Center for Customer Insight (CCI) surveyed more than 1,500 GLP-1 users in nine markets
If you still have questions or would like additional guidance before booking, youre welcome to schedule a FaceTime consultation to ensure you choose the service thats right for you